{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:15:18Z","timestamp":1761174918323,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.cmi.2020.02.033","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T03:05:56Z","timestamp":1582859156000},"page":"799-800","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["'Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea' \u2013 Author\u2019s reply"],"prefix":"10.1016","volume":"26","author":[{"given":"F.","family":"Rob","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Unemo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.02.033_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cmi.2019.08.004","article-title":"Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea: a randomized controlled trial","volume":"26","author":"Rob","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2020.02.033_bib2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/OLQ.0b013e31817bdd7e","article-title":"Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men","volume":"35","author":"Schachter","year":"2008","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.cmi.2020.02.033_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","volume":"5","author":"Unemo","year":"2019","journal-title":"Gonorrhoea Nat Rev Dis Primers"},{"key":"10.1016\/j.cmi.2020.02.033_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/14737159.2017.1360137","article-title":"Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae","volume":"17","author":"Don\u00e0","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cmi.2020.02.033_bib5","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/S1473-3099(17)30310-9","article-title":"Sexually transmitted infections: challenges ahead","volume":"17","author":"Unemo","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2020.02.033_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1071\/SH19023","article-title":"World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts","volume":"16","author":"Unemo","year":"2019","journal-title":"Sex Health"},{"key":"10.1016\/j.cmi.2020.02.033_bib7","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/sti.2010.044586","article-title":"Azithromycin in the treatment of infection with Neisseria gonorrhoeae","volume":"86","author":"Bignell","year":"2010","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.cmi.2020.02.033_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/0956462412472837","article-title":"2012 European guideline on the diagnosis and treatment of gonorrhoea in adults","volume":"24","author":"Bignell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.cmi.2020.02.033_bib9","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea","volume":"59","author":"Kirkcaldy","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.02.033_bib10","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/S0140-6736(18)32817-4","article-title":"Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial","volume":"393","author":"Ross","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2020.02.033_bib11","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1093\/jac\/dkq289","article-title":"Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?","volume":"65","author":"Chisholm","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2020.02.033_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00007435-199403000-00010","article-title":"Multicenter trial of single-dose azithromycin vs. ceftriaxone in the treatment of uncomplicated gonorrhea. Azithromycin Gonorrhea Study Group","volume":"21","author":"Handsfield","year":"1994","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.cmi.2020.02.033_bib13","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1473-3099(18)30162-2","article-title":"Dual antimicrobial therapy for gonorrhoea: what is the role of azithromycin?","volume":"18","author":"Unemo","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2020.02.033_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002366","article-title":"Multidrug-resistant gonorrhea: a research and development roadmap to discover new medicines","volume":"14","author":"Alirol","year":"2017","journal-title":"PLoS Med"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20301373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20301373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:25:48Z","timestamp":1761117948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20301373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1198743X20301373"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.02.033","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"'Gentamicin 240 mg plus azithromycin 2 g vs. ceftriaxone 500 mg plus azithromycin 2 g for treatment of rectal and pharyngeal gonorrhoea' \u2013 Author\u2019s reply","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.02.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.01.035","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.08.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}